Abstract Library

#34 Plasma Chromogranin A(CgA) and Urinary 5 Hydroxy-indoleacetic acid(5-HIAA) use in monitoring somatostatin analogue(SSA) therapy at Newcastle NHS Foundation Trust

Introduction: Two main biochemical markers, plasma chromogranin A (CgA) and urinary 5 hydroxy-indoleacetic acid (5-HIAA) are used to aid staging and monitoring of patients with neuroendocrine (NET) tumors. Somatostatin analogues (SSA) such as octreotide and lanreotide have been used to alleviate symptoms and disease progression in NET patients. This study evaluates the use of CgA and 5HIAA in monitoring NET patients on SSA therapy at Newcastle NHS Foundation Trust.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Teo L, Hearn K, Bernstone G, Wright R, Manus D,

Keywords: CgA, 5-HIAA, octreotide, lanreotide, prognosis, staging, neuroendocrine tumors,